1. Modulatory effects of caffeine on oxidative stress and anxiety-like behavior in ovariectomized rats.
- Author
-
Caravan I, Sevastre Berghian A, Moldovan R, Decea N, Orasan R, and Filip GA
- Subjects
- Animals, Antioxidants pharmacology, Brain drug effects, Brain metabolism, Catalase metabolism, Female, Glutathione blood, Glutathione metabolism, Glutathione Peroxidase metabolism, Hippocampus drug effects, Hippocampus metabolism, Lipid Peroxidation drug effects, Malondialdehyde blood, Malondialdehyde metabolism, Menopause drug effects, Nitric Oxide metabolism, Rats, Anxiety metabolism, Caffeine pharmacology, Maze Learning drug effects, Ovariectomy, Oxidative Stress drug effects
- Abstract
Menopause is accompanied by enhanced oxidative stress and behavioral changes, effects attenuated by antioxidants. The aim of this study was to evaluate the effects of caffeine on behavior and oxidative stress in an experimental model of menopause. Female rats were divided into the following groups: sham-operated (CON), sham-operated and caffeine-treated (CAF), ovariectomized (OVX), ovariectomized and caffeine-treated (OVX+CAF). Caffeine (6 mg/kg) and vehicle were administered for 21 days (subchronic) and 42 days (chronic), using 2 experimental subsets. Behavioral tests and oxidative stress parameters in the blood, whole brain, and hippocampus were assessed. The subchronic administration of caffeine decreased the lipid peroxidation and improved the antioxidant defense in the blood and brain. The GSH/GGSG ratio in the brain was improved by chronic administration, with reduced activities of antioxidant enzymes and enhanced nitric oxide and malondialdehyde levels. In particular, the lipid peroxidation in the hippocampus decreased in both experiments. The rats became hyperactive after 21 days of treatment, but no effect was observed after chronic administration. In both experimental subsets, caffeine had anxiolytic effects as tested in elevated plus maze. The administration of low doses of caffeine, for a short period of time, may be a new therapeutic approach to modulating the oxidative stress and anxiety in menopause.
- Published
- 2016
- Full Text
- View/download PDF